Product Management Service (PMS) webinar on Product User Interface (PUI) edit functionalities for industry users, Online, from 28 January 2025, 10:00 (CET) to 28 January 2025, 12:00 (CET)

Product Management Service (PMS) webinar on Product User Interface (PUI) edit functionalities for industry users, Online, from 28 January 2025, 10:00 (CET) to 28 January 2025, 12:00 (CET)

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Epruvy (previously Ranibizumab Midas), ranibizumab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Epruvy (previously Ranibizumab Midas), ranibizumab, Date of authorisation: 19/09/2024, Revision: 1, Status: Authorised

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - December 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 December 2024, 09:00 (CET) to 11 December 2024, 10:30 (CET)

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - December 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 December 2024, 09:00 (CET) to 11 December 2024, 10:30 (CET)

Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials - Scientific guideline

Guideline on quality, non-clinical and clinical requirements for investigational advanced therapy medicinal products in clinical trials - Scientific guideline

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness